 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Managing Suspected Ventilator-Associated Pneumonia
18 April 2000 | Volume 132 Issue 8 | Page 621
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled " Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia. A Randomized Trial". It is in the 18 April 2000 issue of Annals of Internal Medicine (volume 132, pages 621-630). The authors are.-Y. Fagon, J. Chastre, M. Wolff, C. Gervais, S. Parer-Aubas, F. Stéphan, T. Similowski, A. Mercat, J.-L. Diehl, J.-P. Sollet, and A. Tenaillon, for the VAP Trial Group.
What is the problem and what is known about it so far?
Patients connected to mechanical ventilators ("breathing machines") sometimes develop lung infection. This is known as ventilator-associated pneumonia. Ventilator-associated pneumonia is hard to diagnose because patients on ventilators can develop the usual clinical findings of pneumonia (x-ray changes, fever, bronchial secretions, and bacteria in the respiratory tract) for many reasons other than pneumonia. Treating patients with antibiotics when they do not really have ventilator-associated pneumonia subjects them to the potential side effects and expense of the drugs. Some experts have recommended using invasive tests to diagnose ventilator-associated pneumonia rather than relying on clinical findings. The invasive tests involve inserting an instrument called a bronchoscope into the patient's respiratory tract to obtain samples of lung fluid and tissue. This potentially risky and expensive procedure has never been proven to improve patient outcomes.
Why did the researchers do this particular study?
To find out whether a strategy that involves invasive tests to diagnose ventilator-associated pneumonia is better than a strategy that relies on clinical findings.
Who was studied?
From 31 intensive care units in France, the researchers studied 413 patients suspected of having ventilator-associated pneumonia.
How was the study done?
The researchers randomly assigned patients to the use of either invasive diagnostic tests or clinical findings to guide the diagnosis and treatment of suspected ventilator-associated pneumonia. They then followed these patients to see who died or developed complications involving the heart, kidneys, lungs, nervous system, liver, or blood clotting. They also measured antibiotic use at 14 and 28 days.
What did the researchers find?
After accounting for baseline differences in the groups, patients who underwent the invasive tests were less likely than those in the clinical findings group to have died or suffered organ failure at 14 days. The advantage of using the invasive approach was less clear at 28 days, but the patients who had invasive tests still did better. The invasive strategy patients also had more antibiotic-free days than the clinical findings group.
What were the limitations of the study?
In this study, the doctors were aware of which group the patients were in, which could have influenced the way they prescribed antibiotics. In addition, the tests used to look for bacteria in lung fluids (cultures) in this study may differ from the ones used at other hospitals.
What are the implications of the study?
This study suggests that patients who undergo invasive tests to diagnose and manage suspected ventilator-associated pneumonia do better and spend fewer days taking antibiotics than patients in whom diagnosis and management is guided only by clinical findings.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pelosi, A. Barassi, P. Severgnini, B. Gomiero, S. Finazzi, G. Merlini, G. M. d'Eril, M. Chiaranda, and M. S. Niederman Prognostic Role of Clinical and Laboratory Criteria To Identify Early Ventilator-Associated Pneumonia in Brain Injury Chest, July 1, 2008; 134(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vidaur, K. Planas, R. Sierra, G. Dimopoulos, A. Ramirez, T. Lisboa, and J. Rello Ventilator-Associated Pneumonia: Impact of Organisms on Clinical Resolution and Medical Resources Utilization Chest, March 1, 2008; 133(3): 625 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Moss Clinical Year in Review II: Interstitial Lung Disease, Sepsis, Pulmonary Infections, and Sleep Medicine Proceedings of the ATS, September 15, 2007; 4(6): 482 - 488. [Full Text] [PDF]
|
|
|
|
|
|
G. Horonenko, J. C. Hoyt, R. A. Robbins, C. U. Singarajah, A. Umar, J. Pattengill, and J. M. Hayden Soluble Triggering Receptor Expressed on Myeloid Cell-1 Is Increased in Patients With Ventilator-Associated Pneumonia: A Preliminary Report Chest, July 1, 2007; 132(1): 58 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Meyer, J. Buttler, C. Schneider, E. Strehl, B. Schroeren-Boersch, P. Gastmeier, H. Ruden, J. Zentner, F. D. Daschner, and F. Schwab Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced J. Antimicrob. Chemother., June 1, 2007; 59(6): 1148 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brozek, E. McDonald, F. Clarke, C. Gosse, R. Jaeschke, and D. Cook Pneumonia Observational Incidence and Treatment: A Multidisciplinary Process Improvement Study Am. J. Crit. Care., May 1, 2007; 16(3): 214 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. K. Bahrani-Mougeot, B. J. Paster, S. Coleman, S. Barbuto, M. T. Brennan, J. Noll, T. Kennedy, P. C. Fox, and P. B. Lockhart Molecular Analysis of Oral and Respiratory Bacterial Species Associated with Ventilator-Associated Pneumonia J. Clin. Microbiol., May 1, 2007; 45(5): 1588 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chastre, J.-Y. Fagon, B. Misset, M. Garrouste-Orgeas, J. Carlet, P. E. Marik, M. Baram, D. Heyland, D. Cook, J. Muscedere, et al. Diagnosis of Ventilator-Associated Pneumonia N. Engl. J. Med., April 5, 2007; 356(14): 1469 - 1471. [Full Text] [PDF]
|
|
|
|
|
|
The Canadian Critical Care Trials Group A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia N. Engl. J. Med., December 21, 2006; 355(25): 2619 - 2630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Koenig and J. D. Truwit Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Prince, J. P. Mizgerd, J. Wiener-Kronish, and J. Bhattacharya Cell signaling underlying the pathophysiology of pneumonia Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L297 - L300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Porzecanski and D. L. Bowton Diagnosis and treatment of ventilator-associated pneumonia. Chest, August 1, 2006; 130(2): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Davis Ventilator-associated pneumonia: a review. J Intensive Care Med, July 1, 2006; 21(4): 211 - 226. [Abstract] [PDF]
|
|
|
|
 |
|
 D. E. Craven and R. A. Duncan Preventing Ventilator-associated Pneumonia: Tiptoeing through a Minefield. Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1297 - 1298. [Full Text] [PDF]
|
|
|
|
|
|
B. Afessa, R. D. Hubmayr, E. A. Vetter, M. T. Keegan, K. L. Swanson, L. M. Baddour, F. R. Cockerill III, and S. G. Peters Bronchoscopy in Ventilator-associated Pneumonia: Agreement of Calibrated Loop and Serial Dilution Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1229 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sierra, E. Benitez, C. Leon, and J. Rello Prevention and Diagnosis of Ventilator-Associated Pneumonia: A Survey on Current Practices in Southern Spanish ICUs Chest, September 1, 2005; 128(3): 1667 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A T Jones, R M Du Bois, and A U Wells The pulmonary physician in critical care * Illustrative case 2: Interstitial lung disease Thorax, April 1, 2003; 58(4): 361 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brun-Buisson Antibiotic Therapy of Ventilator-Associated Pneumonia: In Search of the Magic Bullet Chest, March 1, 2003; 123(3): 670 - 673. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Fowler, K. E. Flavin, J. Barr, A. B. Weinacker, J. Parsonnet, and M. K. Gould Variability in Antibiotic Prescribing Patterns and Outcomes in Patients With Clinically Suspected Ventilator-Associated Pneumonia Chest, March 1, 2003; 123(3): 835 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Waterer The Diagnostic Dilemma in Suspected Ventilator-Associated Pneumonia: One Size Will Never Fit All Chest, February 1, 2003; 123(2): 335 - 337. [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Sirvent, L. Vidaur, S. Gonzalez, P. Castro, J. de Batlle, A. Castro, and A. Bonet Microscopic Examination of Intracellular Organisms in Protected Bronchoalveolar Mini-Lavage Fluid for the Diagnosis of Ventilator-Associated Pneumonia Chest, February 1, 2003; 123(2): 518 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hoffken and M. S. Niederman Nosocomial Pneumonia: The Importance of a De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU Chest, December 1, 2002; 122(6): 2183 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Michaud, S. Suzuki, and S. Harbarth Effect of Design-related Bias in Studies of Diagnostic Tests for Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1320 - 1325. [Full Text] [PDF]
|
|
|
|
|
|
A. A. El-Solh, A. T. Aquilina, R. S. Dhillon, F. Ramadan, P. Nowak, and J. Davies Impact of Invasive Strategy on Management of Antimicrobial Treatment Failure in Institutionalized Older People with Severe Pneumonia Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1038 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Lambotte, J.-F. Timsit, M. Garrouste-Orgeas, B. Misset, A. Benali, and J. Carlet The Significance of Distal Bronchial Samples With Commensals in Ventilator-Associated Pneumonia: Colonizer or Pathogen? Chest, October 1, 2002; 122(4): 1389 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Carroll Laboratory Diagnosis of Lower Respiratory Tract Infections: Controversy and Conundrums J. Clin. Microbiol., September 1, 2002; 40(9): 3115 - 3120. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bowton Cultures and Ventilator-Associated Pneumonia : Not How, But How Many Chest, August 1, 2002; 122(2): 401 - 402. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Wu, D. I. Yang, N. Y. Wang, H. T. Kuo, and P. Z. Chen Quantitative Culture of Endotracheal Aspirates in the Diagnosis of Ventilator-Associated Pneumonia in Patients With Treatment Failure* Chest, August 1, 2002; 122(2): 662 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Shorr and M. H. Kollef The Quick and the Dead: The Importance of Rapid Evaluation of Infiltrates in the Immunocompromised Patient Chest, July 1, 2002; 122(1): 9 - 12. [Full Text] [PDF]
|
|
|
|
|
|
A. Combes, C. Figliolini, J.-L. Trouillet, N. Kassis, M. Wolff, C. Gibert, and J. Chastre Incidence and Outcome of Polymicrobial Ventilator-Associated Pneumonia* Chest, May 1, 2002; 121(5): 1618 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Ewig, T Bauer, and A Torres The pulmonary physician in critical care * 4: Nosocomial pneumonia Thorax, April 1, 2002; 57(4): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Balk Is a Silver Coating a Silver Lining? Chest, March 1, 2002; 121(3): 682 - 683. [Full Text] [PDF]
|
|
|
|
|
|
S V Baudouin The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia Thorax, March 1, 2002; 57(3): 267 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Giamarellou Prescribing guidelines for severe Pseudomonas infections J. Antimicrob. Chemother., February 1, 2002; 49(2): 229 - 233. [Full Text] [PDF]
|
|
|
|
|
|
P. Eggimann and D. Pittet Infection Control in the ICU Chest, December 1, 2001; 120(6): 2059 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Brower, L. B. Ware, Y. Berthiaume, and M. A. Matthay Treatment of ARDS Chest, October 1, 2001; 120(4): 1347 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Marik and J. Varon Ventilator-Associated Pneumonia : Science and Hocus-Pocus Chest, September 1, 2001; 120(3): 702 - 704. [Full Text] [PDF]
|
|
|
|
|
|
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia Chest, September 1, 2001; 120(3): 955 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S V Baudouin Ventilator induced lung injury and infection in the critically ill Thorax, September 1, 2001; 56(90002): ii50 - 57. [Full Text] [PDF]
|
|
|
|
|
|
C. ADRIE, M. MONCHI, A. TUAN DINH-XUAN, J. DALL'AVA-SANTUCCI, J.-F. DHAINAUT, and M. R. PINSKY Exhaled and Nasal Nitric Oxide as a Marker of Pneumonia in Ventilated Patients Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1143 - 1149. [Abstract] [Full Text]
|
|
|
|
 |
|
 Additional articles abstracted in ACP Journal Club Evid. Based Med., November 1, 2000; 5(6): 163 - 163. [Full Text]
|
|
|
|
|
|
F. BLOT, B. RAYNARD, E. CHACHATY, C. TANCRÈDE, S. ANTOUN, and G. NITENBERG Value of Gram Stain Examination of Lower Respiratory Tract Secretions for Early Diagnosis of Nosocomial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1731 - 1737. [Abstract] [Full Text]
|
|
|
|
|
|
N. SINGH, P. ROGERS, C. W. ATWOOD, M. M. WAGENER, and V. L. YU Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit . A Proposed Solution for Indiscriminate Antibiotic Prescription Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 505 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Invasive Diagnosis IsBetter in Ventilator-Associated Pneumonia Journal Watch Infectious Diseases, June 1, 2000; 2000(601): 5 - 5. [Full Text]
|
|
|
|
 |
|
 Ventilator-Associated Pneumonia: The Role of Bronchoscopy Journal Watch (General), May 9, 2000; 2000(509): 2 - 2. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
